P21802 (FGFR2_HUMAN) Homo sapiens (Human)
Fibroblast growth factor receptor 2 UniProtKBInterProSTRINGInteractive Modelling
821 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 8; Isoform 14; Isoform 15; Isoform 16; Isoform 17; Isoform 18; Isoform 19; Isoform 20; Isoform 21; Isoform 22; Isoform 23)
Available Structures
56 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 do… |
Heteromer P10686; | 98.01 | 1×ACP; 2×MG; | |||
| CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2… |
Heteromer P09038; | 100.0 | 4×SO4; | |||
| CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 |
Heteromer P09038; | 99.5 | ||||
| LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1 |
Heteromer P05230; | 99.01 | 18×SO4; | |||
| CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 |
Heteromer P09038; | 99.5 | ||||
| CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX |
Heteromer P05230; | 100.0 | 1×SGN; 5×NI; 5×SO4; | |||
| Crystal Structure of FGF1 complexed with the ectodomain of FGFR2b harboring P253R Apert mutation |
Heteromer P05230; | 93.26 | 3×SO4; | |||
| Crystal structure of FGF1 complexed with the ectodomain of FGFR2b harboring the A172F Pfeiffer synd… |
Heteromer P05230; | 93.26 | 3×SO4; | |||
| Crystal Structure Analysis of the FGF10-FGFR2b Complex |
Heteromer O15520; | 93.82 | 2×SO4; 1×15P; | |||
| Crystal Structure of Fibroblast growth factor (FGF)8b in complex with FGF Receptor (FGFR) 2c |
Heteromer P55075; | 99.49 | ||||
| Low resolution crystal structure of the FGFR2D2D3/FGF1/SR128545 complex |
Heteromer P05230; | 100.0 | ||||
| Crystal Structure of 2:2:2 FGFR2D2:FGF1:SOS complex |
Heteromer P05230; | 100 | 2×GU4; | |||
| Crystal structure of the FGFR2 D2 domain in complex with Fab 2B.1.3 |
Heteromer | 100 | ||||
| Structure of phosphotransferase | homo-4-mer | 99.31 | 8×PO4; 4×M33; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation R… | homo-4-mer | 99.65 | 4×SO4; 4×ACP; | |||
| FGFr2 kinase domain | homo-4-mer | 100.0 | 8×SO4; 4×AA2; | |||
| FGFR2 in complex with YJ001 | homo-4-mer | 100.0 | 4×KX0; 1×CL; | |||
| The FGFr2 tyrosine kinase domain | homo-4-mer | 100.0 | 8×SO4; | |||
| FGFR2 Kinase Domain Bound to Irreversible Inhibitor Cmpd 10 | homo-2-mer | 100.0 | 1×GOL; 2×UIM; 1×SO4; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reaction | homo-2-mer | 99.66 | 4×MG; 2×ACP; | |||
| Crystal Structure of Tyrosine Phosphorylated Activated FGF Receptor 2 (FGFR2) Kinase Domain in Comp… | homo-2-mer | 99.65 | 2×MG; 1×ACP; | |||
| Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657 | homo-2-mer | 97.2 | 2×ACP; 2×MG; | |||
| Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain | homo-2-mer | 100.0 | 4×SO4; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation R… | homo-2-mer | 99.64 | 4×SO4; 2×ACP; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation R… | homo-2-mer | 99.64 | 4×SO4; 4×MG; 2×ACP; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation R… | homo-2-mer | 99.3 | 4×SO4; 2×ACP; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation R… | homo-2-mer | 99.64 | 4×SO4; 4×MG; 2×ACP; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation R… | homo-2-mer | 99.64 | 4×SO4; 4×MG; 2×ACP; | |||
| FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29) | homo-2-mer | 99.66 | 2×U9P; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation R… | homo-2-mer | 99.64 | 4×SO4; 2×ACP; | |||
| The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold | homo-2-mer | 99.65 | 2×9WX; | |||
| Crystal Structure of hFGFR2 D2 Domain | homo-2-mer | 100 | ||||
| TAS-120 covalent structure with FGFR2 | monomer | 99.67 | 1×A1AFR; 1×GOL; 3×SO4; | |||
| Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double G… | monomer | 99.0 | 1×FLC; 1×SO4; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function… | monomer | 99.34 | 1×SO4; 1×FLC; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Muta… | monomer | 99.34 | 2×SO4; | |||
| Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with acti… | monomer | 100.0 | 1×WCJ; | |||
| Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3 | monomer | 99.66 | 1×WF7; 1×FLC; 1×GOL; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Muta… | monomer | 99.29 | 2×SO4; 1×ACP; | |||
| Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative | monomer | 100.0 | 1×EVC; 1×SO4; | |||
| Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative | monomer | 100.0 | 1×SO4; 1×EVL; | |||
| TAS-120 covalent structure with FGFR2 molecular brake mutant | monomer | 99.33 | 1×TZ0; 1×GOL; 3×SO4; | |||
| Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069 | monomer | 100.0 | 1×3RH; 5×SO4; | |||
| Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound … | monomer | 99.65 | 1×WFD; 1×FLC; 1×NA; | |||
| TAS-120 covalent structure with FGFR2 molecular brake mutant | monomer | 99.28 | 1×TZ0; 1×SO4; | |||
| FGFR2 Kinase Domain Bound to Reversible Inhibitor Cmpd 3 | monomer | 100.0 | 1×GOL; 1×GSH; 1×WXQ; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation R… | monomer | 99.28 | 1×ACP; 2×SO4; | |||
| TAS-120 covalent structure with FGFR2 molecular brake mutant | monomer | 99.33 | 1×TZ0; 1×SO4; | |||
| Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation | monomer | 99.3 | 1×SO4; 1×ANP; | |||
| Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Ga… | monomer | 98.94 | 2×SO4; 1×ACP; 1×MG; | |||
| Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function… | monomer | 99.64 | 1×ACP; 2×SO4; | |||
| FGFR2 kinase domain (residues 461-763) in complex with 38. | monomer | 100.0 | 1×47I; 1×SO4; | |||
| Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Ga… | monomer | 98.94 | 1×SO4; 1×ACP; 1×MG; | |||
| Solution Structure of the D2 Domain of the Fibroblast Growth Factor | monomer | 100 | ||||
| Crystal structure of the FGFR2 D2 domain | monomer | 100 | ||||
| Crystal structure of D2 domain from human FGFR2 | monomer | 100 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8jqi.1.B | monomer | 0.74 | 72.01 | |||
| 1e0o.1.D | monomer | 0.71 | 1×NI; | 100.00 | ||
| 1ry7.1.B | monomer | 0.67 | 59.55 | |||
43 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8jqi.1.B | monomer | 0.74 | 72.96 | |||
| Isoform 2 | 1e0o.1.D | monomer | 0.72 | 1×NI; | 100.00 | ||
| Isoform 2 | 1ry7.1.B | monomer | 0.68 | 59.55 | |||
| Isoform 3 | 8jqi.1.B | monomer | 0.74 | 70.21 | |||
| Isoform 3 | 1ry7.1.B | monomer | 0.63 | 58.47 | |||
| Isoform 4 | 8jqi.1.B | monomer | 0.76 | 73.30 | |||
| Isoform 4 | 3ojm.1.B | monomer | 0.71 | 99.56 | |||
| Isoform 5 | 8jqi.1.B | monomer | 0.74 | 70.41 | |||
| Isoform 5 | 1e0o.1.D | monomer | 0.71 | 1×NI; | 100.00 | ||
| Isoform 5 | 1ry7.1.B | monomer | 0.67 | 59.55 | |||
| Isoform 6 | 8jqi.1.B | monomer | 0.74 | 71.21 | |||
| Isoform 6 | 1e0o.1.D | monomer | 0.71 | 1×NI; | 100.00 | ||
| Isoform 6 | 1ry7.1.B | monomer | 0.67 | 59.55 | |||
| Isoform 8 | 8jqi.1.B | monomer | 0.74 | 71.24 | |||
| Isoform 8 | 1e0o.1.D | monomer | 0.72 | 1×NI; | 100.00 | ||
| Isoform 8 | 1ry7.1.B | monomer | 0.68 | 59.55 | |||
| Isoform 14 | 5xwt.1.A | monomer | 0.54 | 26.37 | |||
| Isoform 14 | 5noi.1.A | monomer | 0.53 | 25.70 | |||
| Isoform 14 | 7ok5.1.A | monomer | 0.52 | 30.11 | |||
| Isoform 14 | 6fey.1.A | monomer | 0.51 | 14.06 | |||
| Isoform 14 | 8syp.1.L | monomer | 0.50 | 17.28 | |||
| Isoform 15 | 8jqi.1.B | monomer | 0.75 | 72.28 | |||
| Isoform 15 | 1ry7.1.B | monomer | 0.52 | 60.08 | |||
| Isoform 16 | 8jqi.1.B | monomer | 0.74 | 70.41 | |||
| Isoform 16 | 1e0o.1.D | monomer | 0.66 | 1×NI; | 100.00 | ||
| Isoform 16 | 1ry7.1.B | monomer | 0.61 | 59.05 | |||
| Isoform 17 | 8jqi.1.B | monomer | 0.75 | 71.03 | |||
| Isoform 17 | 1ry7.1.B | monomer | 0.65 | 54.49 | |||
| Isoform 18 | 8jqi.1.B | monomer | 0.74 | 68.60 | |||
| Isoform 18 | 1ry7.1.B | monomer | 0.64 | 58.47 | |||
| Isoform 19 | 3ojm.1.B | monomer | 0.76 | 99.10 | |||
| Isoform 19 | 1e0o.1.B | monomer | 0.74 | 1×NI; | 87.62 | ||
| Isoform 19 | 5xwu.1.C | monomer | 0.55 | 25.18 | |||
| Isoform 19 | 7ok5.1.B | monomer | 0.53 | 21.25 | |||
| Isoform 20 | 8jqi.1.B | monomer | 0.75 | 77.03 | |||
| Isoform 20 | 1ev2.1.E | monomer | 0.74 | 98.61 | |||
| Isoform 20 | 1e0o.1.B | monomer | 0.72 | 1×NI; | 99.07 | ||
| Isoform 21 | 8jqi.1.B | monomer | 0.74 | 79.59 | |||
| Isoform 21 | 3oj2.1.B | monomer | 0.73 | 89.73 | |||
| Isoform 21 | 1e0o.1.B | monomer | 0.71 | 1×NI; | 100.00 | ||
| Isoform 22 | 8jqi.1.B | monomer | 0.75 | 78.40 | |||
| Isoform 22 | 3ojm.1.B | monomer | 0.72 | 99.56 | |||
| Isoform 23 | 8jqi.1.B | monomer | 0.75 | 63.29 | |||